Two controlling persons of the CRO giant are under investigation by the CSRC! | Selected After-Hours Announcements
Two controlling shareholders of a CRO giant have been investigated by the CSRC! A well-known liquor company announced that its actual controller has changed to the Municipal Finance Bureau; a wind power giant urgently clarified that its shareholder is not a popular male star...
Suspected of violations and illegal activities related to information disclosure on shareholding changes! The actual controller of a 40 billion CRO leading company has been investigated by the CSRC | Post-market announcement highlights
Vanke A: Shenzhen Metro Group provides the company with a RMB 2.5 billion shareholder loan facility, and the company signs a supplementary agreement for the RMB 22 billion shareholder loan.
The solid-state battery industry summit is approaching, with the industrialization process continuing to advance, and these stocks frequently being surveyed by institutions.
The 3rd AEPT Solid-State Battery Industry Summit and the 2026 Starting Point Solid-State Battery Technology Forum will be held in Shanghai from June 16 to 17, 2026.
Market sentiment for going long has fully warmed up, with a focus on rotation and catch-up opportunities within the technology supply chain.
Track the entire lifecycle of the mainline sector.
The daily online signing volume of second-hand housing transactions in Shanghai has reached a new high in five years, and the fundamentals of the real estate industry may continue to improve.
①Data from the official website of Shanghai Real Estate Trading Center, 'Online Real Estate,' showed that on May 10 (Sunday), a total of 1,664 second-hand housing units (including commercial properties) were transacted online in a single day in Shanghai, breaking the five-year single-day online transaction record for the second time in a month. ②Looking ahead, He Miannan of Everbright Securities believes that leading central and state-owned enterprises with obvious credit advantages will continue to benefit from the industry's supply-side deleveraging and optimization of competitive structure, driving performance stabilization and recovery.
Low stock prices prompt shareholders to urge share repurchases; Kanghong Pharmaceutical plans to invest over 1 billion yuan annually in R&D in the future | Earnings meeting coverage
①During the earnings call, several participants expressed dissatisfaction with the current stock price of Kanghong Pharmaceutical and suggested that the company take various measures to boost investor confidence; ②Kanghong Pharmaceutical also shared updates on the progress of its highly anticipated R&D pipeline.